Anubha Bajaj*

Consultant, Histopathologist, A.B. Diagnostics, India

*Corresponding Author: Anubha Bajaj, Consultant, Histopathologist, A.B. Diagnostics, India.

Received: October 14, 2022; Published: November 01, 2022

Chondromyxoid fibroma is designated as an infrequent, benign, cartilaginous neoplasm commonly incriminating proximal or distal segments of long bones. Upregulation of GRM1 is pathognomonic feature associated with chondromyxoid fibroma although molecular assay remains superfluous for ascertaining chondromyxoid fibroma.

Bibliography

1. Elzouiti Z., et al. “Chondromyxoid fibroma of zygomatic bone: A case report”. Annals of Medicine and Surgery (Lond) 75 (2022): 103394.
2. Toland AMS., et al. “GRM1 Immunohistochemistry Distinguishes Chondromyxoid Fibroma From its Histologic Mimics”. The American Journal of Surgical Pathology 10 (2022): 1407-1414.
3. Oh SJ and Chung SH. “Juxtacortical chondromyxoid fibroma in the small bones: two cases with unusual location and a literature review”. Journal of Pathology and Translational Medicine 3 (2022): 157-160.
4. Li C., et al. “Chondromyxoid fibroma of the cervical spine: A case report”. World Journal of Clinical Cases 17 (2022): 5748-5755.
5. Image 1 Courtesy: Pathology outlines.
6. Image 2 Courtesy: Springer link.

Citation: Anubha Bajaj. “Soggy and Muculent - Chondromyxoid Fibroma". Acta Scientific Clinical Case Reports 3.12 (2022): 01-03.

Copyright: © 2022 Anubha Bajaj. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.